Your browser doesn't support javascript.
loading
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Bartlett, Nancy L; Herrera, Alex F; Domingo-Domenech, Eva; Mehta, Amitkumar; Forero-Torres, Andres; Garcia-Sanz, Ramon; Armand, Philippe; Devata, Sumana; Izquierdo, Antonia Rodriguez; Lossos, Izidore S; Reeder, Craig; Sher, Taimur; Chen, Robert; Schwarz, Sylvia E; Alland, Leila; Strassz, Andras; Prier, Kim; Choe-Juliak, Cassandra; Ansell, Stephen M.
Afiliação
  • Bartlett NL; Department of Medicine, Division of Oncology, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO.
  • Herrera AF; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Domingo-Domenech E; Department of Hematology, Institut Català d'Oncologia, Hospital Duran i Reynals, Hospitalet de Llobregat, Barcelona, Spain.
  • Mehta A; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Forero-Torres A; Division of Hematology & Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Garcia-Sanz R; Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Devata S; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI.
  • Izquierdo AR; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Lossos IS; Hematological Malignancies Site Disease Group, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
  • Reeder C; Hematology Department, Mayo Clinic, Scottsdale, AZ.
  • Sher T; Department of Medicine, Mayo Clinic, Jacksonville, FL.
  • Chen R; Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
  • Schwarz SE; Affimed GmbH, Heidelberg, Germany.
  • Alland L; Affimed, Inc., New York, NY; and.
  • Strassz A; Affimed GmbH, Heidelberg, Germany.
  • Prier K; Affimed GmbH, Heidelberg, Germany.
  • Choe-Juliak C; Affimed, Inc., New York, NY; and.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN.
Blood ; 136(21): 2401-2409, 2020 11 19.
Article em En | MEDLINE | ID: mdl-32730586
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de IgG / Antígeno Ki-1 / Imunoterapia / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Macau
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de IgG / Antígeno Ki-1 / Imunoterapia / Antígenos de Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Macau